Bank of New York Mellon’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.3M | Buy |
117,616
+28,407
| +32% | +$4.9M | ﹤0.01% | 1511 |
|
2025
Q1 | $13.9M | Sell |
89,209
-9,183
| -9% | -$1.43M | ﹤0.01% | 1690 |
|
2024
Q4 | $13.5M | Sell |
98,392
-6,826
| -6% | -$940K | ﹤0.01% | 1772 |
|
2024
Q3 | $15.7M | Sell |
105,218
-5,423
| -5% | -$810K | ﹤0.01% | 1708 |
|
2024
Q2 | $15.1M | Sell |
110,641
-40,303
| -27% | -$5.5M | ﹤0.01% | 1737 |
|
2024
Q1 | $22.8M | Sell |
150,944
-62,225
| -29% | -$9.41M | ﹤0.01% | 1500 |
|
2023
Q4 | $26.8M | Sell |
213,169
-19,593
| -8% | -$2.47M | 0.01% | 1447 |
|
2023
Q3 | $21.8M | Sell |
232,762
-83,234
| -26% | -$7.79M | ﹤0.01% | 1496 |
|
2023
Q2 | $28.2M | Buy |
315,996
+70,577
| +29% | +$6.3M | 0.01% | 1361 |
|
2023
Q1 | $26.3M | Sell |
245,419
-5,231
| -2% | -$561K | 0.01% | 1396 |
|
2022
Q4 | $30.6M | Sell |
250,650
-10,791
| -4% | -$1.32M | 0.01% | 1303 |
|
2022
Q3 | $27M | Sell |
261,441
-8,505
| -3% | -$878K | 0.01% | 1318 |
|
2022
Q2 | $25.1M | Sell |
269,946
-19,398
| -7% | -$1.8M | 0.01% | 1414 |
|
2022
Q1 | $34M | Buy |
289,344
+49,298
| +21% | +$5.79M | 0.01% | 1355 |
|
2021
Q4 | $32.3M | Sell |
240,046
-2,087
| -0.9% | -$281K | 0.01% | 1430 |
|
2021
Q3 | $38.6M | Sell |
242,133
-20,837
| -8% | -$3.32M | 0.01% | 1309 |
|
2021
Q2 | $34.6M | Buy |
262,970
+156
| +0.1% | +$20.5K | 0.01% | 1414 |
|
2021
Q1 | $33.9M | Buy |
262,814
+100,790
| +62% | +$13M | 0.01% | 1383 |
|
2020
Q4 | $27M | Buy |
162,024
+9,831
| +6% | +$1.64M | 0.01% | 1445 |
|
2020
Q3 | $23.5M | Buy |
152,193
+15,156
| +11% | +$2.34M | 0.01% | 1373 |
|
2020
Q2 | $20.3M | Buy |
137,037
+9,820
| +8% | +$1.45M | 0.01% | 1433 |
|
2020
Q1 | $14.3M | Sell |
127,217
-6,900
| -5% | -$777K | ﹤0.01% | 1499 |
|
2019
Q4 | $18.7M | Buy |
+134,117
| New | +$18.7M | ﹤0.01% | 1612 |
|
2019
Q1 | – | Sell |
-123,415
| Closed | -$7.73M | – | 4201 |
|
2018
Q4 | $7.73M | Buy |
+123,415
| New | +$7.73M | ﹤0.01% | 2056 |
|